Name | Number of supported studies | Average coverage | |
---|---|---|---|
conventional dendritic cell | 12 studies | 22% ± 8% | |
plasmacytoid dendritic cell | 10 studies | 37% ± 17% | |
T cell | 7 studies | 20% ± 4% | |
natural killer cell | 6 studies | 26% ± 10% | |
CD4-positive, alpha-beta T cell | 6 studies | 21% ± 2% | |
CD8-positive, alpha-beta T cell | 6 studies | 22% ± 6% | |
gamma-delta T cell | 6 studies | 26% ± 7% | |
macrophage | 6 studies | 20% ± 4% | |
monocyte | 6 studies | 20% ± 4% | |
astrocyte | 5 studies | 21% ± 5% | |
glutamatergic neuron | 5 studies | 38% ± 21% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 25% ± 8% | |
smooth muscle cell | 4 studies | 17% ± 1% | |
innate lymphoid cell | 4 studies | 30% ± 13% | |
GABAergic neuron | 4 studies | 37% ± 16% | |
group 3 innate lymphoid cell | 4 studies | 44% ± 20% | |
mononuclear phagocyte | 3 studies | 16% ± 0% | |
dendritic cell | 3 studies | 21% ± 4% | |
epithelial cell | 3 studies | 18% ± 1% | |
myeloid cell | 3 studies | 24% ± 11% | |
Mueller cell | 3 studies | 27% ± 12% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 3% | |
pericyte | 3 studies | 18% ± 1% | |
interneuron | 3 studies | 34% ± 20% | |
mature NK T cell | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 786.22 | 578 / 578 | 100% | 8.15 | 1155 / 1155 |
breast | 100% | 934.07 | 459 / 459 | 100% | 11.16 | 1117 / 1118 |
prostate | 100% | 929.69 | 245 / 245 | 100% | 11.16 | 501 / 502 |
adrenal gland | 100% | 1513.51 | 258 / 258 | 100% | 12.82 | 229 / 230 |
thymus | 100% | 1750.05 | 653 / 653 | 100% | 14.13 | 602 / 605 |
esophagus | 100% | 694.78 | 1444 / 1445 | 99% | 8.01 | 182 / 183 |
bladder | 100% | 734.81 | 21 / 21 | 99% | 7.44 | 500 / 504 |
pancreas | 100% | 478.07 | 328 / 328 | 99% | 7.34 | 176 / 178 |
uterus | 100% | 1039.42 | 170 / 170 | 99% | 7.89 | 453 / 459 |
kidney | 100% | 751.83 | 89 / 89 | 99% | 8.73 | 889 / 901 |
brain | 99% | 522.49 | 2604 / 2642 | 100% | 10.89 | 704 / 705 |
intestine | 100% | 733.44 | 966 / 966 | 98% | 6.45 | 517 / 527 |
ovary | 100% | 3163.49 | 180 / 180 | 97% | 5.22 | 417 / 430 |
stomach | 100% | 625.49 | 359 / 359 | 97% | 6.20 | 277 / 286 |
skin | 100% | 835.47 | 1806 / 1809 | 97% | 9.66 | 457 / 472 |
liver | 100% | 475.73 | 226 / 226 | 86% | 3.83 | 350 / 406 |
adipose | 100% | 953.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1033.49 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.21 | 29 / 29 |
spleen | 100% | 705.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.85 | 1 / 1 |
muscle | 99% | 511.75 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 560.46 | 826 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 6.82 | 72 / 80 |
peripheral blood | 70% | 365.23 | 652 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019919 | Biological process | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine |
GO_0006397 | Biological process | mRNA processing |
GO_0032259 | Biological process | methylation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0005737 | Cellular component | cytoplasm |
GO_0035243 | Molecular function | protein-arginine omega-N symmetric methyltransferase activity |
GO_0016274 | Molecular function | protein-arginine N-methyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRMT9 |
Protein name | Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320) Protein arginine methyltransferase 9 |
Synonyms | PRMT10 |
Description | FUNCTION: Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA). Specifically mediates the symmetrical dimethylation of SF3B2. Involved in the regulation of alternative splicing of pre-mRNA . . |
Accessions | ENST00000322396.7 [Q6P2P2-1] Q6P2P2 ENST00000514886.1 D6REN0 |